| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/RHEUMATOLOGY/40.1.62 |
| P698 | PubMed publication ID | 11157143 |
| P2093 | author name string | E Murphy | |
| B Bresnihan | |||
| O FitzGerald | |||
| G Cunnane | |||
| A Madigan | |||
| P433 | issue | 1 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 62-69 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis | |
| P478 | volume | 40 |
| Q35835741 | A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm |
| Q37245184 | A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue |
| Q35219001 | An expanding role for interleukin-1 blockade from gout to cancer |
| Q24795018 | Are synovial biopsies of diagnostic value? |
| Q52955456 | Cell source-dependent in vivo immunosuppressive properties of mesenchymal stem cells derived from the bone marrow and synovial fluid of minipigs. |
| Q35553008 | Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis |
| Q38894091 | Control of autoimmune inflammation by celastrol, a natural triterpenoid |
| Q27345563 | Decrease of CD68 Synovial Macrophages in Celastrol Treated Arthritic Rats |
| Q33728489 | Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1. |
| Q30488975 | Evaluation of arthroscopy and macroscopic scoring |
| Q35225125 | Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports |
| Q35683994 | Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions |
| Q35084908 | Infection complications associated with the use of biologic agents |
| Q35133812 | Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives |
| Q35994130 | Is there a role of synovial biopsy in drug development? |
| Q43904323 | Lidocaine inhibits secretion of IL-8 and IL-1beta and stimulates secretion of IL-1 receptor antagonist by epithelial cells |
| Q90853964 | Liquid biopsies to guide therapeutic decisions in rheumatoid arthritis |
| Q52730350 | Mesenchymal stem cells ameliorate experimental arthritis via expression of interleukin-1 receptor antagonist. |
| Q39803090 | Microscopic measurement of inflammation in synovial tissue: inter-observer agreement for manual quantitative, semiquantitative and computerised digital image analysis |
| Q57771987 | Novel targets and new potential: developments in the treatment of inflammation in chronic kidney disease |
| Q38798012 | Osteoarthritis: Pathology, Mouse Models, and Nanoparticle Injectable Systems for Targeted Treatment |
| Q35760103 | Real-time quantitative PCR to detect changes in synovial gene expression in rheumatoid arthritis after corticosteroid treatment |
| Q36617118 | Regulation of osteoclast differentiation and function by interleukin-1. |
| Q24817151 | Reliability of computerized image analysis for the evaluation of serial synovial biopsies in randomized controlled trials in rheumatoid arthritis |
| Q34420356 | Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion |
| Q64101100 | Single-cell correlations of mRNA and protein content in a human monocytic cell line after LPS stimulation |
| Q36173601 | Standardisation of synovial tissue infiltrate analysis: how far have we come? How much further do we need to go? |
| Q41913676 | Successful treatment of rheumatoid arthritis is associated with a reduction in serum sE-selectin and thrombomodulin level |
| Q39701973 | Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis |
| Q39431367 | Synovial tissue research: a state-of-the-art review |
| Q28200818 | The balance between IL-1 and IL-1Ra in disease |
| Q36790391 | The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis |
| Q41822795 | The needle and the damage done |
| Q36617121 | The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation. |
| Q33771582 | Toll-like receptor-mediated production of IL-1Ra is negatively regulated by GSK3 via the MAPK ERK1/2. |
| Q36816872 | Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases |
| Q37636664 | Treating inflammation by blocking interleukin-1 in humans |
| Q33185559 | Treatment of rheumatoid arthritis by interleukin-1 receptor antagonist |
| Q33833871 | Why not treat human cancer with interleukin-1 blockade? |
| Q53855814 | [Biologicals in treatment of rheumatoid arthritis and other inflammatory arthropathies]. |
Search more.